Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Quantitation of Cirtuvivint (SM08502) in Human Plasma by LC-MS/MS.
Journal: Biomedical chromatography : BMC
Published: April 15, 2026
Signaling Mutations Negate the Favorable Impact of NPM1 Mutations in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With VEN/HMA.
Journal: American journal of hematology
Published: April 02, 2026
Real-world analysis of CPX-351 in AML-MR: A multicentre study from the MARROW consortium.
Journal: British journal of haematology
Published: September 11, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed NPM1-Mutated or KMT2A-Rearranged AML.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: June 12, 2025
Precision Medicine in Myeloid Neoplasia: Challenges and Opportunities.
Journal: Journal of personalized medicine
Published: November 05, 2024
SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis.
Journal: Clinical lymphoma, myeloma & leukemia
Published: August 13, 2024
Dissecting Out a Rare Mutation, STAT: Features of STAT3-Mutant Myeloid Neoplasms.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 18, 2024
Favorable outcomes in MDS and oligoblastic AML-MR after reduced-intensity conditioning allogeneic bone marrow transplantation with post-transplantation cyclophosphamide.
Journal: Bone marrow transplantation
Published: April 14, 2024
Management of patients with concurrent clonal plasma cell and myeloid disorders: A single center descriptive case series.
Journal: Leukemia research reports
Published: February 01, 2024
SOHO State of the Art Updates and Next Questions: An Update on Higher Risk Myelodysplastic Syndromes.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 31, 2024
The Times, They Are A-Changing: The Impact of Next-Generation Sequencing on Diagnosis, Classification, and Prognostication of Myeloid Malignancies With Focus on Myelodysplastic Syndrome, AML, and Germline Predisposition.
Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Published: June 12, 2023
Prognostic impact of secondary versus de novo ontogeny in acute myeloid leukemia is accounted for by the European LeukemiaNet 2022 risk classification.
Journal: Leukemia
Published: May 22, 2023
Last Updated: 09/26/2026